2018
DOI: 10.1007/s00405-018-5083-4
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of GJB2 mutations and the clinical manifestation in a large Hungarian cohort

Abstract: The mutation frequency of GJB2 in the investigated cohort is lower than in other European cohorts. The most serious cases were associated with homozygous and compound heterozygous mutations. In our cohort the hearing impairment and age of onset was not altered between in cases with only one heterozygous GJB2 mutation and wild type genotype, which may exclude the possibility of autosomal dominant inheritance. In early onset, severe to profound hearing loss cases, if the GJB2 analysis results in only one heteroz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
8
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 29 publications
3
8
0
1
Order By: Relevance
“…Genetic diagnosis was confirmed in 174 (59.7%) of the 291 patients with different degrees of hearing impairment, most of them being accounted for GJB2 gene. This data is in accordance with the literature, GJB2 mutations are frequent in all studied populations [13,14,[33][34][35][36][37][38]. In some populations GJB2 mutations are prevalent due to consanguineous marriages.…”
Section: Discussionsupporting
confidence: 93%
“…Genetic diagnosis was confirmed in 174 (59.7%) of the 291 patients with different degrees of hearing impairment, most of them being accounted for GJB2 gene. This data is in accordance with the literature, GJB2 mutations are frequent in all studied populations [13,14,[33][34][35][36][37][38]. In some populations GJB2 mutations are prevalent due to consanguineous marriages.…”
Section: Discussionsupporting
confidence: 93%
“…GJB2 mutation is a major cause of hereditary NSHL, and most mutations are located in the coding region [49]. Up to 50% of cases of autosomal recessive NSHL are attributable to GJB2 mutation in many populations worldwide [29,30]. Therefore, genetic testing for GJB2 mutations is a primary screening process for the molecular diagnosis of HL.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, several alleles have been found to be particularly enriched in certain populations: c.35delG in Europe, America, North Africa, and the Middle East; c.71G>A in India and Pakistan; c.167delT in Ashkenazi Jews; and c.109G>A in East and Southeast Asia [ 16 , 26 28 ]. The contribution of GJB2 mutations to genetic HL varies by ethnicity, but such mutations are the primary cause of congenital severe-to-profound autosomal recessive NSHL (up to 50% worldwide) [ 29 , 30 ]. In addition, mild and moderate HL are associated with GJB2 common mutations such as c.35delG and c.109G>A, showing diverse hearing phenotypes [ 31 , 32 ].…”
Section: Introductionmentioning
confidence: 99%
“…Ez a mutáció Európában a leggyakoribb patogén eltérés, homozigótahordozás esetén súlyos fokú halláscsökkenés, míg compound heterozigóta formában a halláscsökkenés széles spektruma alakulhat ki [17]. Korábbi tanulmányunkban, melynek során felnőtt és gyermek, kisfokútól súlyos fokig terjedő halláscsökkenéssel rendelkező betegek körében vizsgáltuk a különböző mutációk előfordulása és klinikai megjelenésük közötti összefüggést, csak 12,6%-os c.35delG-allélfrekvenciát találtunk [18]. Jelen vizsgálatunk rámutat, hogy a súlyos fokú halláscsökkent betegek között nagy találati eredményt kapunk, így ezt a genetikai vizsgálatot elsősorban ebben a betegpopulációban érdemes elvégezni.…”
Section: áBraunclassified